AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 153.04 +0.34 (+0.22%)MSFT 105 +0.23 (+0.22%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Financial Summary IFRX Quote InflaRx N.V

InflaRx N.V. Quote

InflaRx N.V. (IFRX)

36.11 4.01 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
D+
Symbol IFRX
Price 36.11
Beta -0.04
Vol Avg 66.13 K
Mkt cap 706.78 M
Shares 23
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE 69.23% Strong Buy
ROA -60.00% Strong Sell
Operating Margin -Infinity% Strong Sell
Debt/Equity -211.54% Sell
P/E -92.28 Strong Sell
P/B -31.94 Strong Sell
Company Profile

CEO

Niels Riedemann

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.